Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1087

1.

Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.

Sanghavi SK, Abu-Elmagd K, Keightley MC, St George K, Lewandowski K, Boes SS, Bullotta A, Dare R, Lassak M, Husain S, Kwak EJ, Paterson DL, Rinaldo CR.

J Clin Virol. 2008 Aug;42(4):335-42. doi: 10.1016/j.jcv.2008.03.031. Epub 2008 May 21.

PMID:
18495527
2.
3.
5.

Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients.

Hernando S, Folgueira L, Lumbreras C, San Juan R, Maldonado S, Prieto C, Babiano MJ, Delgado J, Andres A, Moreno E, Aguado JM, Otero JR.

Transplant Proc. 2005 Nov;37(9):4094-6.

PMID:
16386635
6.

Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid-organ transplant recipients.

Storch GA, Buller RS, Bailey TC, Ettinger NA, Langlois T, Gaudreault-Keener M, Welby PL.

J Clin Microbiol. 1994 Apr;32(4):997-1003.

7.
8.

Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients.

Gimeno C, Solano C, Latorre JC, Hernández-Boluda JC, Clari MA, Remigia MJ, Furió S, Calabuig M, Tormo N, Navarro D.

J Clin Microbiol. 2008 Oct;46(10):3311-8. doi: 10.1128/JCM.00797-08. Epub 2008 Aug 27.

9.

Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay.

Gouarin S, Vabret A, Gault E, Petitjean J, Regeasse A, Hurault de Ligny B, Freymuth F.

J Clin Virol. 2004 Mar;29(3):194-201.

PMID:
14962789
10.

Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.

Ksouri H, Eljed H, Greco A, Lakhal A, Torjman L, Abdelkefi A, Ben Othmen T, Ladeb S, Slim A, Zouari B, Abdeladhim A, Ben Hassen A.

Transpl Infect Dis. 2007 Mar;9(1):16-21.

PMID:
17313466
11.

Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients.

Garrigue I, Boucher S, Couzi L, Caumont A, Dromer C, Neau-Cransac M, Tabrizi R, Schrive MH, Fleury H, Lafon ME.

J Clin Virol. 2006 May;36(1):72-5. Epub 2006 Feb 14.

PMID:
16481215
13.

Quantitation of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia.

Mengelle C, Pasquier C, Rostaing L, Sandres-Sauné K, Puel J, Berges L, Righi L, Bouquies C, Izopet J.

J Med Virol. 2003 Feb;69(2):225-31.

PMID:
12683412
14.

Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma.

Leruez-Ville M, Ouachée M, Delarue R, Sauget AS, Blanche S, Buzyn A, Rouzioux C.

J Clin Microbiol. 2003 May;41(5):2040-6.

15.
17.

Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.

Schvoerer E, Henriot S, Zachary P, Freitag R, Fuchs A, Fritsch S, Risch S, Meyer N, Caillard S, Lioure B, Stoll-Keller F.

J Med Virol. 2005 May;76(1):76-81.

PMID:
15778970
18.

Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.

Martín-Dávila P, Fortún J, Gutiérrez C, Martí-Belda P, Candelas A, Honrubia A, Barcena R, Martínez A, Puente A, de Vicente E, Moreno S.

J Clin Virol. 2005 Jun;33(2):138-44. Epub 2004 Dec 16.

PMID:
15911429
19.

Evaluation of the AmpliSensor PCR and the SHARP signal detection system for the early prediction of symptomatic CMV infection in solid transplant recipients.

Rautenberg P, Lübbert C, Weers W, Boetel E, Schweichler J, Zhou L, Costard-Jäckle A, Kraemer-Hansen H, Harder TC.

J Clin Virol. 1999 Jun;13(1-2):81-94.

PMID:
10405895
20.

Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.

Lilleri D, Baldanti F, Gatti M, Rovida F, Dossena L, De Grazia S, Torsellini M, Gerna G.

J Med Virol. 2004 Jul;73(3):412-8.

PMID:
15170637

Supplemental Content

Support Center